Sienna Biopharmaceuticals, Inc. Stock Split Ratio
Sienna Biopharmaceuticals, Inc. had Stock Split Ratio of 17.04% as of 2017-07-20, per its 10-K filed 2019-03-14.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2019-03-14
- 2017-07-20: Stockholders' Equity Note, Stock Split, Conversion Ratio 17.04%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio |
|---|---|
| 2017-07-20 | 17.04% 10-K · filed 2019-03-14 |